vs
Side-by-side financial comparison of Dime Community Bancshares, Inc. (DCOM) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $123.8M, roughly 1.3× Dime Community Bancshares, Inc.). On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 3040.1%).
The Dime Community Bank, originally known as the Dime Savings Bank of Williamsburgh, is a local, FDIC-insured bank headquartered in Hauppauge, New York. Founded in 1864, the bank was originally based in the Williamsburg neighborhood of Brooklyn, New York, and continues to operate with a strong market presence in this area. In 2017, Dime moved its headquarters to Brooklyn Heights. On Monday, February 1, 2021, Bridge Bancorp Inc. and Dime Community Bancshares successfully closed on a merger of ...
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
DCOM vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $158.6M |
| Net Profit | — | $112.9M |
| Gross Margin | — | — |
| Operating Margin | 38.6% | 70.2% |
| Net Margin | — | 71.2% |
| Revenue YoY | 3040.1% | 3661.1% |
| Net Profit YoY | — | 528.0% |
| EPS (diluted) | $0.68 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | — | ||
| Q3 25 | $115.6M | — | ||
| Q2 25 | $109.7M | — | ||
| Q1 25 | $103.8M | $158.6M | ||
| Q4 24 | $3.9M | $22.6M | ||
| Q3 24 | $87.6M | — | ||
| Q2 24 | $87.3M | — | ||
| Q1 24 | $82.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | $27.7M | — | ||
| Q2 25 | $29.7M | — | ||
| Q1 25 | $21.5M | $112.9M | ||
| Q4 24 | — | $-10.5M | ||
| Q3 24 | $13.3M | — | ||
| Q2 24 | $18.5M | — | ||
| Q1 24 | $17.7M | — |
| Q4 25 | 38.6% | — | ||
| Q3 25 | 34.7% | — | ||
| Q2 25 | 36.6% | — | ||
| Q1 25 | 27.6% | 70.2% | ||
| Q4 24 | -433.6% | -60.4% | ||
| Q3 24 | 20.8% | — | ||
| Q2 24 | 29.8% | — | ||
| Q1 24 | 29.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | 23.9% | — | ||
| Q2 25 | 27.1% | — | ||
| Q1 25 | 20.7% | 71.2% | ||
| Q4 24 | — | -46.4% | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 21.6% | — |
| Q4 25 | $0.68 | — | ||
| Q3 25 | $0.59 | — | ||
| Q2 25 | $0.64 | — | ||
| Q1 25 | $0.45 | $1.90 | ||
| Q4 24 | $-0.58 | $-0.15 | ||
| Q3 24 | $0.29 | — | ||
| Q2 24 | $0.43 | — | ||
| Q1 24 | $0.41 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $350.1M |
| Total Assets | $15.3B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $274.8M | ||
| Q4 24 | — | $128.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | $350.1M | ||
| Q4 24 | $1.4B | $229.0M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | $15.3B | — | ||
| Q3 25 | $14.5B | — | ||
| Q2 25 | $14.2B | — | ||
| Q1 25 | $14.1B | $406.9M | ||
| Q4 24 | $14.4B | $271.6M | ||
| Q3 24 | $13.7B | — | ||
| Q2 24 | $13.5B | — | ||
| Q1 24 | $13.5B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $186.6M | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $186.6M | — | ||
| Q3 25 | $52.1M | — | ||
| Q2 25 | $23.1M | — | ||
| Q1 25 | $65.4M | $131.8M | ||
| Q4 24 | $99.1M | $-23.2M | ||
| Q3 24 | $-33.3M | — | ||
| Q2 24 | $12.6M | — | ||
| Q1 24 | $30.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | $51.2M | — | ||
| Q2 25 | $20.4M | — | ||
| Q1 25 | — | $131.7M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | $-34.1M | — | ||
| Q2 24 | $9.2M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 44.3% | — | ||
| Q2 25 | 18.6% | — | ||
| Q1 25 | — | 83.0% | ||
| Q4 24 | — | -102.7% | ||
| Q3 24 | -38.9% | — | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.88× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 3.05× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.50× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 1.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
